- Home
- Products
- Customized FluoroAb™
- VEGFA
- Anti-VEGFA MAb (Clone 13)-iFluor® 532 Succinimidyl Ester
Anti-VEGFA MAb (Clone 13)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13856)
This product is comprised of an Humanized Anti-VEGFA Fab-G1-kappa (Clone 13) labeled with iFluor® 532 Succinimidyl Ester. iFluor® 532 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- VEGFA
- Alternative Names
- MVCD1; Vascular permeability factor; VEGF-A; VPF; VEGF; Vascular endothelial growth factor A
- Overview
- VEGF is an angiogenic growth factor and a prognostic indicator for cancer when detected in serum. VG-1 is useful for studies of VEGF and angiogenesis in human pathological material.
- Overview
- Humanized Anti-VEGFA Fab-G1-kappa (Clone 13)
- Species Reactivity
- Human
- Name
- iFluor® 532 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 537/560
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CCR4 MAb (Clone 2)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5711)
- Anti-CCL2 MAb (Clone 1)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS10925)
- Anti-TNFRSF8 MAb (Clone 2)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8049)
- Anti-CD4 MAb (Clone 21)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8844)
- Anti-LAMP1 MAb (Clone 2)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6434)
- Anti-CD79B MAb (Clone 5)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9553)
- Sulesomab-PBlue (CAT#: ADC-FL-972)
- Anti-IGF1 MAb (Clone 2)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11375)
- Anti-CD19 MAb (Clone 1)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14004)
- Itolizumab-Cy3 (CAT#: ADC-FL-878)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS13856. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-1932 | Anti-VEGFA (Bevacizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-2293 | Anti-VEGFA (Vanucizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-2291 | Anti-VEGFA (Vanucizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-1939 | Anti-VEGFA (Ranibizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-2292 | Anti-VEGFA (Vanucizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
